Literature DB >> 26652379

Fabrication of SnO2/porous silica/polyethyleneimine nanoparticles for pH-responsive drug delivery.

Na Cao1, Miao Li2, Yanbao Zhao3, Li Qiu1, Xueyan Zou1, Yu Zhang2, Lei Sun1.   

Abstract

To create novel nanocarriers for achieving excellent drug delivery performance, pH-responsive fluorescent porous silica (PS) nanocarriers were developed by encapsulating SnO2 nanoparticles and coating polyethyleneimine (PEI) layer. SnO2/porous silica (SnO2/PS) nanoparticles have an average diameter of 80nm and center-radial large pore channels. The large channels endow them high surface area with a Brunauer-Emmett-Teller (BET) area of 939m(2)g(-1). Aspirin was used as test drug to evaluate the releasing behavior of SnO2/porous silica/polyethyleneimine (SnO2/PS/PEI) nanoparticles. Results indicated that aspirin can be successfully incorporated into the SnO2/PS/PEI nanoparticles and the SnO2/PS/PEI nanoparticles displayed excellent pH-responsive release. The release rate in pH7.4 buffer is higher than that in pH5.5 buffer, which attributed to the PEI structure change in varied pH buffer. In addition, the SnO2/PS/PEI nanoparticles presented novel drug-dependent fluorescence, which could be used to trace the drug release.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug delivery; Drug-dependent fluorescence; Nanocarriers; SnO(2)/porous silica/polyethyleneimine; pH-responsive

Mesh:

Substances:

Year:  2015        PMID: 26652379     DOI: 10.1016/j.msec.2015.10.032

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  2 in total

1.  Chromium removal from aqueous solution by a PEI-silica nanocomposite.

Authors:  Keunsu Choi; Soonjae Lee; Jin Ock Park; Jeong-Ann Park; So-Hye Cho; Seung Yong Lee; Jun Hee Lee; Jae-Woo Choi
Journal:  Sci Rep       Date:  2018-01-23       Impact factor: 4.379

2.  Development of a tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of fenofibrate.

Authors:  Andi Bai; Chao Wu; Xuan Liu; Huiling Lv; Xiaoyan Xu; Yue Cao; Wenjing Shang; Lili Hu; Ying Liu
Journal:  Drug Des Devel Ther       Date:  2018-07-10       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.